跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Rapzar - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Rapzar
Approved
STANDARD
Rapzar
Azarias Pharmaceutical Laboratories Inc.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
0ccbc736947e4ee1
Company
Azarias Pharmaceutical Laboratories Inc.
Type
Standard
Approval Details
Approval Id
0ccbc736947e4ee1
Drug Approval Philippines Name
Rapzar
Product Name
Rapzar
Registration Number
DRP-12412-02
Brand Name
Rapzar
Generic Name
Losartan Potassium
Dosage Form
Film-Coated Tablet
Dosage Strength
50 mg
Manufacturer
Azarias Pharmaceutical Laboratories Inc.
Distributor
St. Raphael Archangel Pharmaceutical Product Distribution
Issuance Date
28 September 2022
Expiry Date
03 August 2025
Pharmacologic Category
Angiotensin II Receptor Antagonist
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
0ccbc736947e4ee1
Type
Standard
Back to Philippines FDA Approvals